Kristy Murray-Pulsifer, DO
Family Medicine · South Portland, MENPI 1356310098
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,804 of the $55,172 with a category attached, or 95.7%. 4 manufacturers reported payments, led by Organon at 47.0% of the total. Reporting peaked in 2021 at $23,210 and has fallen 80.1% since, to $4,618 in 2025. Among family medicine clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $586.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$26K
- Biohaven Pharmaceuticals, Inc.$17K
- Merck$11K
- Impel Pharmaceuticals Inc.$855
What the payments were for
- Speaking & faculty fees$52,80496%
- Travel & lodging$5721%
- Food & beverage$1,7963%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 47 | $25,904 |
| Biohaven Pharmaceuticals, Inc. | 26 | $16,975 |
| Merck | 18 | $11,438 |
| Impel Pharmaceuticals Inc. | 3 | $855 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$32,168
- NURTEC ODT$16,685
- Trudhesa$835
How this compares
$55,172 in reported general payments places this provider in the 95th percentile of 466 family medicine providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 50 | $72,757 |
| XareltoRivaroxaban | 16 | $26,331 |
| TrulicityDulaglutide | 22 | $22,882 |
| MounjaroTirzepatide | 21 | $21,068 |
| OzempicSemaglutide | 21 | $19,335 |
| JardianceEmpagliflozin | 12 | $15,277 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $8,826 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,276 |
| Bupropion XlBupropion Hcl | 120 | $5,502 |
| SynthroidLevothyroxine Sodium | 50 | $4,134 |
| Levothyroxine Sodium | 312 | $2,623 |
| Omeprazole | 140 | $2,537 |
| Gabapentin | 93 | $2,277 |
| Atorvastatin Calcium | 241 | $1,975 |
| ValacyclovirValacyclovir Hcl | 35 | $1,892 |
Paid to pharmacies, not to this prescriber.
Other family medicine in South Portland
- Mary ConnollySouth Portland$1K
- Michael CiampiSouth Portland$1K
- Meaghan JohnsonSouth Portland$734
- Katherine CampbellSouth Portland$681
- Albert HartmanLewiston$33K
- Brian KnightonFreeport$29K
- Edward YoonPortland$27K
- Jennifer FreeseVeazie$19K
- Kohar der SimonianFalmouth$18K
- Jessica Bloom FosterBangor$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.